Inovio Links With GeneOne For MERS Immunotherapy
This article was originally published in PharmAsia News
Executive Summary
Amid the recent climb in the number of confirmed cases of lethal Middle East Respiratory Syndrome (MERS) in South Korea, Inovio Pharmaceuticals and GeneOne Life Science have said they will advance Inovio's DNA vaccine for MERS into a clinical trial in healthy volunteers.